The Founders News
Business News

Bharti Global Secures 24.5% Stake in BT Group, Strengthening Telecom Alliances

Bharti Global, the international investment division of Bharti Enterprises, has successfully acquired 24.5% of the issued share capital of BT Group plc from Altice UK. This strategic move solidifies Bharti’s commitment to the telecom giant’s growth and global aspirations.

Sunil Bharti Mittal, Chair of Bharti Enterprises, expressed his enthusiasm over the milestone, highlighting Bharti’s confidence in BT’s potential. Mittal underscored the transformative possibilities this investment offers, emphasizing the alignment of BT’s vision with Bharti’s strategic goals.

In a statement, Mittal praised BT’s ongoing initiatives aimed at network optimization, bolstering infrastructure, and fostering consumer-centric growth. He noted that such efforts position BT as a leading player in the global telecom landscape, ensuring sustainable value creation for its stakeholders.

This acquisition marks a significant step for Bharti Global in expanding its footprint within the global telecommunications sector. By becoming a key shareholder in BT Group, Bharti aims to strengthen ties with a company renowned for its innovation and market leadership.

Mittal reaffirmed Bharti’s long-standing belief in BT’s capabilities and its potential to lead in an evolving telecom environment. “We’re delighted to have completed our investment into BT,” he said, expressing optimism about the collaboration’s prospects for delivering long-term value to both companies and their investors.

Related posts

Hyundai Motor India to Launch $3 Billion IPO Next Week: Key Details on Its Operations

The Founders News

From Burnout to Balance: Managing Stress as an Entrepreneur

The Founders News

Emcure Pharma’s Strong Stock Market Debut

The Founders News

UK-India Finalize Major Trade Deal

The Founders News

Government Investigates E-Commerce Practices of Amazon, Flipkart, Apple, and Xiaomi: What You Need to Know

The Founders News

Neuralink Launches First International Clinical Trial in Abu Dhabi

The Founders News